ProMIS Neurosciences Cash Per Share vs. Current Valuation

PMN Stock  USD 0.95  0.05  5.56%   
Based on ProMIS Neurosciences' profitability indicators, ProMIS Neurosciences may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess ProMIS Neurosciences' ability to earn profits and add value for shareholders.
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
1.36290575
Current Value
1.29
Quarterly Volatility
3.61728692
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of the 4th of December 2024, Price To Sales Ratio is likely to drop to 5,071. In addition to that, Days Sales Outstanding is likely to drop to 1.92. At this time, ProMIS Neurosciences' Interest Income is very stable compared to the past year. As of the 4th of December 2024, Net Income Per E B T is likely to grow to 1.01, though Accumulated Other Comprehensive Income is likely to grow to (467.2 K).
For ProMIS Neurosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ProMIS Neurosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ProMIS Neurosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ProMIS Neurosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ProMIS Neurosciences over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.04
Revenue Per Share
0.001
Return On Assets
(4.81)
Return On Equity
(10.99)
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ProMIS Neurosciences Current Valuation vs. Cash Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ProMIS Neurosciences's current stock value. Our valuation model uses many indicators to compare ProMIS Neurosciences value to that of its competitors to determine the firm's financial worth.
ProMIS Neurosciences is regarded fourth in cash per share category among its peers. It is rated below average in current valuation category among its peers reporting about  6,658,355  of Current Valuation per Cash Per Share. At this time, ProMIS Neurosciences' Cash Per Share is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ProMIS Neurosciences' earnings, one of the primary drivers of an investment's value.

ProMIS Current Valuation vs. Cash Per Share

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

ProMIS Neurosciences

Cash Per Share

 = 

Total Cash

Average Shares

 = 
1.24 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

ProMIS Neurosciences

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
8.26 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

ProMIS Current Valuation vs Competition

ProMIS Neurosciences is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 302.76 Million. ProMIS Neurosciences holds roughly 8.26 Million in current valuation claiming about 2.73% of equities under Health Care industry.

ProMIS Neurosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ProMIS Neurosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ProMIS Neurosciences will eventually generate negative long term returns. The profitability progress is the general direction of ProMIS Neurosciences' change in net profit over the period of time. It can combine multiple indicators of ProMIS Neurosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-491.8 K-467.2 K
Operating Income-18.9 M-18 M
Income Before Tax-17.5 M-16.6 M
Total Other Income Expense Net1.4 M1.4 M
Net Loss-17.5 M-16.6 M
Income Tax Expense-167.9 K-159.5 K
Net Interest Income-124.6 K-130.8 K
Net Loss-16.9 M-16.1 M
Net Loss-16.3 M-17.1 M
Interest Income5.4 K5.7 K
Change To Netincome-4.2 M-4 M
Net Loss(1.42)(1.50)
Income Quality 0.82  0.66 
Net Income Per E B T 0.81  1.01 

ProMIS Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ProMIS Neurosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ProMIS Neurosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ProMIS Neurosciences' important profitability drivers and their relationship over time.

Use ProMIS Neurosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.

ProMIS Neurosciences Pair Trading

ProMIS Neurosciences Pair Trading Analysis

The ability to find closely correlated positions to ProMIS Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProMIS Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProMIS Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProMIS Neurosciences to buy it.
The correlation of ProMIS Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProMIS Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your ProMIS Neurosciences position

In addition to having ProMIS Neurosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Semiconductor Thematic Idea Now

Semiconductor
Semiconductor Theme
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
View All  Next Launch
When determining whether ProMIS Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProMIS Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock:
Check out Your Equity Center.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project ProMIS Neurosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ProMIS Neurosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ProMIS Neurosciences' income statement, its balance sheet, and the statement of cash flows.
Potential ProMIS Neurosciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ProMIS Neurosciences investors may work on each financial statement separately, they are all related. The changes in ProMIS Neurosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ProMIS Neurosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.